Indefinite Delivery Contract SPE2DR25D3002

The Indefinite Delivery Contract (IDC) SPE2DR25D3002 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC serves as a primary vehicle for the DLA to efficiently procure essential medical commodities required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The IDC was awarded as a result of a pre-solicitation issued by the DLA for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement. This unrestricted, fully competitive acquisition aims to establish multiple regional Prime Vendor Contracts to provide worldwide pharmaceutical support to the Defense Health Agency, Department of Defense, U.S. Coast Guard, and other government customers. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made to the responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall price based on distribution fees.